Literature DB >> 9713065

Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.

C H Kon1, N L Occleston, A Foss, C Sheridan, G W Aylward, P T Khaw.   

Abstract

AIM: To investigate the effects of single, short-term (5 or 30 minutes) exposures to thiotepa or 5-fluorouracil (5-FU) on collagen lattice contraction and retinal pigment epithelial (RPE) cell proliferation.
METHODS: For collagen contraction studies, RPE cells seeded into free floating type I collagen lattices were exposed to single 5 or 30 minute treatments with thiotepa (0.06-4 mg/ml), or 5-FU (0.25-25 mg/ml), or phosphate buffered saline alone as a control. For proliferation studies, RPE cell monolayers were similarly exposed to these agents. The degree of contraction, effects on cell number, and viability were determined up to 14 days after treatment.
RESULTS: Contraction of collagen lattices containing RPE cells and proliferation of RPE cells were significantly inhibited (p < 0.05) by thiotepa and 5-FU at concentrations above 0.06 mg/ml and 0.25 mg/ml respectively (for both 5 and 30 minute treatments), compared with controls. Cell death did not occur except for exposure of the RPE cells in collagen lattices to the highest concentration of thiotepa (4 mg/ml).
CONCLUSION: It was concluded that single 5 or 30 minute exposures to thiotepa or 5-FU significantly inhibited collagen contraction and the proliferation of RPE cells. These findings suggest that short, single, non-toxic exposures to thiotepa or 5-FU which can be reproduced clinically may be useful in the modulation of proliferative vitreoretinopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9713065      PMCID: PMC1722588          DOI: 10.1136/bjo.82.5.554

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts.

Authors:  P T Khaw; S Ward; A Porter; I Grierson; R A Hitchings; N S Rice
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-05       Impact factor: 4.799

2.  Trials of intravitreal injections of chemotherapeutic agents in rabbits.

Authors:  L Ericson; B Karlberg; B H Rosengren
Journal:  Acta Ophthalmol (Copenh)       Date:  1964

3.  Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation).

Authors:  R Machemer; H Laqua
Journal:  Am J Ophthalmol       Date:  1975-07       Impact factor: 5.258

4.  Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study.

Authors:  P S Hiscott; I Grierson; D McLeod
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

5.  The management of pterygium.

Authors:  D Ehrlich
Journal:  Ophthalmic Surg       Date:  1977-04

6.  Culture of mammalian retinal pigment epithelium and neural retina.

Authors:  R B Edwards
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Evaluation of intravitreal 5-fluorouracil, vincristine, VP 16, doxorubicin, and thiotepa in primate eyes.

Authors:  A Barrada; G A Peyman; J Case; G Fishman; A Thomas; R Fiscella
Journal:  Ophthalmic Surg       Date:  1984-09

8.  Effects of single exposures to antiproliferative agents on ocular fibroblast-mediated collagen contraction.

Authors:  N L Occleston; R A Alexander; A Mazure; G Larkin; P T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-09       Impact factor: 4.799

9.  Fluorouracil for the treatment of massive periretinal proliferation.

Authors:  M S Blumenkranz; A Ophir; A J Claflin; A Hajek
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

10.  Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines.

Authors:  M S Blumenkranz; M K Hartzer; A S Hajek
Journal:  Arch Ophthalmol       Date:  1987-03
View more
  6 in total

1.  Gene therapy: new "magic bullets" to prevent ocular scarring.

Authors:  P T Khaw; A D Cambrey; G A Limb; J T Daniels
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

Review 2.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  In Vitro Cell Models for Ophthalmic Drug Development Applications.

Authors:  Sara Shafaie; Victoria Hutter; Michael T Cook; Marc B Brown; David Y S Chau
Journal:  Biores Open Access       Date:  2016-04-01

4.  Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis.

Authors:  Chen Chen; Peng Chen; Xia Liu; Hua Li
Journal:  Front Med (Lausanne)       Date:  2021-11-30

5.  Quinotrierixin inhibits proliferation of human retinal pigment epithelial cells.

Authors:  Chen Chen; Joshua J Wang; Jingming Li; Qiang Yu; Sarah X Zhang
Journal:  Mol Vis       Date:  2013-01-07       Impact factor: 2.367

6.  Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding.

Authors:  Claudia S Priglinger; Jara Obermann; Christoph M Szober; Juliane Merl-Pham; Uli Ohmayer; Jennifer Behler; Fabian Gruhn; Thomas C Kreutzer; Christian Wertheimer; Arie Geerlof; Siegfried G Priglinger; Stefanie M Hauck
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.